245 related articles for article (PubMed ID: 26153509)
21. Discrepancy between left ventricular hypertrophy by echocardiography and electrocardiographic hypertrophy: clinical characteristics and outcomes.
Seko Y; Kato T; Yamaji Y; Haruna Y; Nakane E; Haruna T; Inoko M
Open Heart; 2021 Sep; 8(2):. PubMed ID: 34556560
[TBL] [Abstract][Full Text] [Related]
22. Factors associated with diagnostic discrepancy for left ventricular hypertrophy between electrocardiography and echocardiography.
Petersen SS; Pedersen LR; Pareek M; Nielsen ML; Diederichsen SZ; Leósdóttir M; Nilsson PM; Diederichsen AC; Olsen MH
Blood Press; 2017 Feb; 26(1):54-63. PubMed ID: 27662908
[TBL] [Abstract][Full Text] [Related]
23. Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study.
Larstorp AC; Okin PM; Devereux RB; Olsen MH; Ibsen H; Dahlöf B; Kjeldsen SE; Wachtell K
J Hum Hypertens; 2011 Mar; 25(3):178-85. PubMed ID: 20505749
[TBL] [Abstract][Full Text] [Related]
24. Prognostic implications of left ventricular hypertrophy diagnosed on electrocardiogram vs echocardiography.
Pedersen LR; Kristensen AMD; Petersen SS; Vaduganathan M; Bhatt DL; Juel J; Byrne C; Leósdóttir M; Olsen MH; Pareek M
J Clin Hypertens (Greenwich); 2020 Sep; 22(9):1647-1658. PubMed ID: 32813895
[TBL] [Abstract][Full Text] [Related]
25. Comparison of usefulness of Sokolow and Cornell criteria for left ventricular hypertrophy in subjects aged <20 years versus >30 years.
Grossman A; Prokupetz A; Koren-Morag N; Grossman E; Shamiss A
Am J Cardiol; 2012 Aug; 110(3):440-4. PubMed ID: 22534054
[TBL] [Abstract][Full Text] [Related]
26. Electrocardiographic and echocardiographic detection of myocardial infarction in patients with left-ventricular hypertrophy. The LIFE Study.
Cicala S; Devereux RB; de Simone G; Wachtell K; Gerdts E; Boman K; Nieminen MS; Papademetriou V; Dahlöf B; Okin PM
Am J Hypertens; 2007 Jul; 20(7):771-6. PubMed ID: 17586412
[TBL] [Abstract][Full Text] [Related]
27. Left ventricular hypertrophy is a predictor of cardiovascular events in elderly hypertensive patients: Hypertension in the Very Elderly Trial.
Antikainen RL; Peters R; Beckett NS; Fagard RH; Wang JG; Rajkumar C; Bulpitt CJ
J Hypertens; 2016 Nov; 34(11):2280-6. PubMed ID: 27552643
[TBL] [Abstract][Full Text] [Related]
28. Electrocardiographic left ventricular hypertrophy and the risk of adverse cardiovascular events: a critical appraisal.
Rautaharju PM; Soliman EZ
J Electrocardiol; 2014; 47(5):649-54. PubMed ID: 25012077
[TBL] [Abstract][Full Text] [Related]
29. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Dahlof B;
Circulation; 2003 Aug; 108(6):684-90. PubMed ID: 12885747
[TBL] [Abstract][Full Text] [Related]
30. Left ventricular hypertrophy and risk of cardiac failure: insights from the Framingham Study.
Kannel WB; Levy D; Cupples LA
J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S135-40. PubMed ID: 2485019
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme.
Hawkins NM; Wang D; McMurray JJ; Pfeffer MA; Swedberg K; Granger CB; Yusuf S; Pocock SJ; Ostergren J; Michelson EL; Dunn FG;
Heart; 2007 Jan; 93(1):59-64. PubMed ID: 16952975
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of electrocardiographic criteria for left ventricular hypertrophy.
Hsieh BP; Pham MX; Froelicher VF
Am Heart J; 2005 Jul; 150(1):161-7. PubMed ID: 16084164
[TBL] [Abstract][Full Text] [Related]
33. Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.
Okin PM; Devereux RB; Gerdts E; Snapinn SM; Harris KE; Jern S; Kjeldsen SE; Julius S; Edelman JM; Lindholm LH; Dahlöf B;
Circulation; 2006 Mar; 113(12):1588-96. PubMed ID: 16534012
[TBL] [Abstract][Full Text] [Related]
34. Electrocardiography is a poor screening test to detect left ventricular hypertrophy in children.
Killian L; Simpson JM; Savis A; Rawlins D; Sinha MD
Arch Dis Child; 2010 Oct; 95(10):832-6. PubMed ID: 20656727
[TBL] [Abstract][Full Text] [Related]
35. Cohort Study of ECG Left Ventricular Hypertrophy Trajectories: Ethnic Disparities, Associations With Cardiovascular Outcomes, and Clinical Utility.
Iribarren C; Round AD; Lu M; Okin PM; McNulty EJ
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28982671
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular prognosis in patients with type 2 diabetes: contribution of heart and kidney subclinical damage.
Sosner P; Hulin-Delmotte C; Saulnier PJ; Cabasson S; Gand E; Torremocha F; Piguel X; Miot A; Maréchaud R; Herpin D; Ragot S; Hadjadj S;
Am Heart J; 2015 Jan; 169(1):108-14.e7. PubMed ID: 25497255
[TBL] [Abstract][Full Text] [Related]
37. Association of electrocardiographic left ventricular hypertrophy with incident cardiovascular disease in Japanese older hypertensive patients.
Edison ES; Yano Y; Hoshide S; Kario K
Am J Hypertens; 2015 Apr; 28(4):527-34. PubMed ID: 25267736
[TBL] [Abstract][Full Text] [Related]
38. [Left ventricular hypertrophy; differences in the diagnostic and prognostic value of electrocardiography and echocardiography].
Dijkstra RF; van Schayck CP; Bakx JC; Thien T; Verheugt FW; Mokkink HG
Ned Tijdschr Geneeskd; 1997 Oct; 141(41):1969-72. PubMed ID: 9550747
[TBL] [Abstract][Full Text] [Related]
39. Prognostic usefulness of left ventricular hypertrophy by electrocardiography in patients with atrial fibrillation (from the Randomized Evaluation of Long-Term Anticoagulant Therapy Study).
Verdecchia P; Reboldi G; Di Pasquale G; Mazzotta G; Ambrosio G; Yang S; Pogue J; Wallentin L; Ezekowitz MD; Connolly SJ; Yusuf S;
Am J Cardiol; 2014 Feb; 113(4):669-75. PubMed ID: 24359765
[TBL] [Abstract][Full Text] [Related]
40. Do Combined Electrocardiographic and Echocardiographic Markers of Left Ventricular Hypertrophy Improve Cardiovascular Risk Estimation?
Cuspidi C; Facchetti R; Sala C; Bombelli M; Tadic M; Grassi G; Mancia G
J Clin Hypertens (Greenwich); 2016 Sep; 18(9):846-54. PubMed ID: 27160298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
